LogicBio Therapeutics
- Biological Products, Except Diagnostic Substances
- Lexington, Massachusetts
Compensation history
Top executives at LogicBio Therapeutics received an average of $1M per person in annual compensation from 2017 to 2021.
Average pay of disclosed executives at LogicBio Therapeutics
By year
Executives
We found nine executives who work or worked at LogicBio Therapeutics.
Frederic Chereau
LogicBio Therapeutics
Chief Executive Officer
Daniel Gruskin
LogicBio Therapeutics
Chief Medical Officer
Cecilia Jones
LogicBio Therapeutics
Chief Financial Officer
Mariana Nacht
LogicBio Therapeutics
Chief Scientific Officer
Kyle Chiang
LogicBio Therapeutics
Chief Operating Officer
Bryan Yoon
LogicBio Therapeutics
Chief Administrative Officer
Kenneth Huttner
LogicBio Therapeutics
Senior Vice President, Head of Clinical Development
Dean Falb
LogicBio Therapeutics
Chief Scientific Officer
News
LogicBio Therapeutics CEO Frederic Chereau's 2021 pay rises 20% to $2.2M
April 29, 2022
LogicBio Therapeutics CEO Frederic Chereau's 2020 pay jumps 193% to $1.9M
April 27, 2021
LogicBio Therapeutics Senior Vice President, Head of Clinical Development Kenneth Huttner receives $765K in 2019
April 29, 2020
LogicBio Therapeutics COO Sandra Poole receives $2.1M in 2018
April 29, 2019
About LogicBio Therapeutics
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryBiological Products, Except Diagnostic Substances
- Address65 Hayden Ave, 2nd Floor, Lexington, Massachusetts 02421
- Phone617-245-0399
- Fiscal year endDecember 31
Source: SEC filings on April 29, 2022, April 27, 2021, April 29, 2020, and April 29, 2019.